Esperion Therapeutics
ESPR
#6169
Rank
โ‚ฌ0.75 B
Marketcap
3,20ย โ‚ฌ
Share price
-1.58%
Change (1 day)
-2.73%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2025 (TTM): -โ‚ฌ25.47 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are โ‚ฌ0.30 Billion. In 2024 the company made an earning of โ‚ฌ6.44 Million, an increase over its 2023 earnings that were of -โ‚ฌ0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ25.47 Million-494.96%
2024 โ‚ฌ6.44 M-104.99%
2023 -โ‚ฌ0.13 Billion-15.03%
2022 -โ‚ฌ0.16 Billion-20.61%
2021 -โ‚ฌ0.2 Billion84.28%
2020 -โ‚ฌ0.11 Billion35.75%
2019 -โ‚ฌ76.49 Million-55.71%
2018 -โ‚ฌ0.18 Billion19.57%
2017 -โ‚ฌ0.15 Billion125.39%
2016 -โ‚ฌ64.08 Million51.43%
2015 -โ‚ฌ42.32 Million36.45%
2014 -โ‚ฌ31.02 Million43.55%
2013 -โ‚ฌ21.61 Million145.26%
2012 -โ‚ฌ8.81 Million
2002 -โ‚ฌ25.12 Million-7.81%
2001 -โ‚ฌ27.24 Million15.03%
2000 -โ‚ฌ23.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-โ‚ฌ0.45 Billion 1,790.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ0.58 B-2,575.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ10.17 B-43,290.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ4.41 B-18,849.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚ฌ4.27 M-118.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-โ‚ฌ58.91 Million 149.91%๐Ÿ‡บ๐Ÿ‡ธ USA